Literature DB >> 12958266

Diagnosis of tick-borne encephalitis by a mu-capture immunoglobulin M-enzyme immunoassay based on secreted recombinant antigen produced in insect cells.

Anu Jääskeläinen1, Xiuqi Han, Matthias Niedrig, Antti Vaheri, Olli Vapalahti.   

Abstract

Acute tick-borne encephalitis is diagnosed by detection of IgM antibodies to tick-borne encephalitis virus (TBEV) (genus Flavivirus) in patient serum. TBEV membrane (M) and envelope (E) proteins have previously been shown to form virus-like particles when expressed in mammalian cells. We expressed the prM/M and E proteins in insect cells with a recombinant baculovirus system and obtained antigenic protein secreted into the cell culture medium, as evidenced by detection by a panel of five monoclonal antibodies to TBEV E protein. According to the sedimentation pattern in sucrose gradient centrifugation, the proteins were most likely secreted as virus-like particles. A mu-capture immunoglobulin M-enzyme immunoassay (IgM-EIA) test was developed and compared to a commercially available TBEV-IgM test (Progen) based on inactivated purified TBEVs. With a panel of 100 TBEV-IgM-negative, 50 TBEV-IgM-positive, and seven dengue virus-IgM-positive serum samples from our diagnostic laboratory, a sensitivity of 100% and specificity of 99% were obtained, and the correlation coefficient of EIA absorbances with the reference test was 0.93. The antigen was also suitable for IgG antibody detection in an immunofluorescent assay format. This is the first time that secreted, fully antigenic E protein has been produced in insect cells for this arthropod-borne flavivirus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958266      PMCID: PMC193853          DOI: 10.1128/JCM.41.9.4336-4342.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.

Authors:  U Klockmann; K Krivanec; J R Stephenson; J Hilfenhaus
Journal:  Vaccine       Date:  1991-03       Impact factor: 3.641

2.  Tick-borne encephalitis: possibly a fatal disease in its acute stage. PCR amplification of TBE RNA from postmortem brain tissue.

Authors:  J Tomazic; M Poljak; P Popovic; M Maticic; B Beovic; T Avsic-Zupanc; S Lotric; M Jereb; F Pikelj; N Gale
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

3.  Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia.

Authors:  M Ecker; S L Allison; T Meixner; F X Heinz
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

4.  Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles.

Authors:  E Konishi; A Fujii; P W Mason
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Arboviruses in Finland. I. Isolation of tick-borne encephalitis (TBE) virus from arthropods, vertebrates, and patients.

Authors:  M Brummer-Korvenkontio; P Saikku; P Korhonen; N Oker-Blom
Journal:  Am J Trop Med Hyg       Date:  1973-05       Impact factor: 2.345

6.  Characterization of tick-borne encephalitis virus from Latvia: evidence for co-circulation of three distinct subtypes.

Authors:  S Vene; I Golovljova; V Mavtchoutko; M Forsgren; V Kalnina; A Plyusnin
Journal:  J Med Virol       Date:  2001-12       Impact factor: 2.327

7.  Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form.

Authors:  S L Allison; K Stadler; C W Mandl; C Kunz; F X Heinz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.

Authors:  A R Hunt; C B Cropp; G J Chang
Journal:  J Virol Methods       Date:  2001-09       Impact factor: 2.014

Review 9.  A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy.

Authors:  M Haglund; M Forsgren; G Lindh; L Lindquist
Journal:  Scand J Infect Dis       Date:  1996

10.  Prevalence of tick-borne encephalitis virus in Ixodes ricinus ticks in Finland.

Authors:  X Han; M Aho; S Vene; M Peltomaa; A Vaheri; O Vapalahti
Journal:  J Med Virol       Date:  2001-05       Impact factor: 2.327

View more
  7 in total

1.  Gadolinium enhancement of cauda equina: a new MR imaging finding in the radiculitic form of tick-borne encephalitis.

Authors:  S Marjelund; A Jaaskelainen; T Tikkakoski; S Tuisku; O Vapalahti
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

2.  Immunofluorescence assay for detection of human metapneumovirus-specific antibodies by use of baculovirus-expressed fusion protein.

Authors:  Nobuhisa Ishiguro; Takashi Ebihara; Rika Endo; Xiaoming Ma; Ryo Shirotsuki; Susumu Ochiai; Hiroaki Ishiko; Hideaki Kikuta
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

3.  Detection of specific antibodies against tembusu virus in ducks by use of an E protein-based enzyme-linked immunosorbent assay.

Authors:  Xiuchen Yin; Rang Lv; Xiaodan Chen; Ming Liu; Ronghong Hua; Yun Zhang
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

4.  Diagnostic potential and antigenic properties of recombinant tick-borne encephalitis virus subviral particles expressed in mammalian cells from Semliki Forest virus replicons.

Authors:  Lev Levanov; Suvi Kuivanen; Andrey Matveev; Sathyamangalam Swaminathan; Anu Jääskeläinen-Hakala; Olli Vapalahti
Journal:  J Clin Microbiol       Date:  2013-12-26       Impact factor: 5.948

Review 5.  Plant-Derived Recombinant Vaccines against Zoonotic Viruses.

Authors:  Gergana Zahmanova; Katerina Takova; Rumyana Valkova; Valentina Toneva; Ivan Minkov; Anton Andonov; Georgi L Lukov
Journal:  Life (Basel)       Date:  2022-01-21

6.  Identification of linear human B-cell epitopes of tick-borne encephalitis virus.

Authors:  Suvi Kuivanen; Jussi Hepojoki; Sirkka Vene; Antti Vaheri; Olli Vapalahti
Journal:  Virol J       Date:  2014-06-19       Impact factor: 4.099

7.  Multi-laboratory evaluation of ReaScan TBE IgM rapid test, 2016 to 2017.

Authors:  Bo Albinsson; Anu E Jääskeläinen; Kairi Värv; Mateja Jelovšek; Corine GeurtsvanKessel; Sirkka Vene; Josef D Järhult; Chantal Reusken; Irina Golovljova; Tatjana Avšič-Županc; Olli Vapalahti; Åke Lundkvist
Journal:  Euro Surveill       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.